Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionBessemer Group Inc
Latest Disclosed Ownership248 shares
Latest Disclosed Value $ 14
Bessemer Group Inc reports 5.08% increase in ownership of HAE / Haemonetics Corporation

On May 6, 2026 - Bessemer Group Inc filed a 13F-HR form disclosing ownership of 248 shares of Haemonetics Corporation (US:HAE) valued at $13,977 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 236 shares of Haemonetics Corporation. The current value of the position is $17,677 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F HAEMONETICS CORP MASS SC 405024100 248 12 5.08 0 0.0000
2026-02-05 2025-12-31 13F HAEMONETICS CORP MASS SC 405024100 236 -36 -13.24 0 0.0000
2025-11-05 2025-09-30 13F HAEMONETICS CORP MASS SC 405024100 272 63 30.14 0 0.0000
2025-08-01 2025-06-30 13F HAEMONETICS CORP MASS SC 405024100 209 68 48.23 0 0.0000
2025-04-23 2025-03-31 13F HAEMONETICS CORP MASS SC 405024100 141 16 12.80 0 0.0000
2025-02-13 2024-12-31 13F HAEMONETICS CORP MASS SC 405024100 125 -628 -83.40 0 0.0000
2024-11-12 2024-09-30 13F HAEMONETICS CORP MASS SC 405024100 753 201 36.41 0 0.0001
2024-08-13 2024-06-30 13F HAEMONETICS CORP MASS SC 405024100 552 515 1,391.89 0 0.0001
2024-08-13 2024-03-31 13F/A-1 HAEMONETICS CORP MASS SC 405024100 37 -9 -19.57 0 0.0000
2024-05-13 2024-03-31 13F HAEMONETICS CORP MASS SC 405024100 37 -9 0 0.0000
2024-02-09 2023-12-31 13F HAEMONETICS CORP MASS SC 405024100 46 -42 -47.73 0 0.0000
2023-11-13 2023-09-30 13F HAEMONETICS CORP MASS SC 405024100 88 46 109.52 0 0.0000
2023-08-10 2023-06-30 13F HAEMONETICS CORP MASS SC 405024100 42 42 0 0.0000
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS SC 405024100 0 0 0 0.0000
2020-11-12 2020-09-30 13F HAEMONETICS CORP MASS SC 405024100 0 -44,800 -100.00 0 -100.00
2020-08-05 2020-06-30 13F HAEMONETICS CORP MASS SC 405024100 44,800 0 0.00 4,012 -10.15 0.0127
2020-04-30 2020-03-31 13F HAEMONETICS CORP MASS SC 405024100 44,800 1,700 3.94 4,465 -9.83 0.0180
2020-02-04 2019-12-31 13F HAEMONETICS CORP MASS SC 405024100 43,100 300 0.70 4,952 -8.28 0.0160
2019-11-07 2019-09-30 13F HAEMONETICS CORP MASS SC 405024100 42,800 900 2.15 5,399 7.08 0.0193
2019-07-19 2019-06-30 13F HAEMONETICS CORP MASS SC 405024100 41,900 7,000 20.06 5,042 65.15 0.0170
2019-05-13 2019-03-31 13F HAEMONETICS CORP MASS SC 405024100 34,900 1,000 2.95 3,053 -9.99 0.0117
2019-05-21 2018-12-31 13F/A-1 HAEMONETICS CORP MASS SC 405024100 33,900 5,700 20.21 3,392 4.98 0.0148
2019-02-12 2018-12-31 13F HAEMONETICS CORP MASS SC 405024100 33,900 5,700 3,392 0.0148
2018-11-06 2018-09-30 13F HAEMONETICS CORP MASS SC 405024100 28,200 -600 -2.08 3,231 25.09 0.0120
2018-07-25 2018-06-30 13F HAEMONETICS CORP MASS SC 405024100 28,800 -2,500 -7.99 2,583 12.79 0.0100
2018-05-10 2018-03-31 13F HAEMONETICS CORP MASS SC 405024100 31,300 -6,700 -17.63 2,290 3.76 0.0089
2018-01-30 2017-12-31 13F HAEMONETICS CORP MASS SC 405024100 38,000 -20,700 -35.26 2,207 -16.21 0.0086
2017-11-03 2017-09-30 13F HAEMONETICS CORP MASS SC 405024100 58,700 700 1.21 2,634 15.02 0.0105
2017-07-27 2017-06-30 13F HAEMONETICS CORP MASS SC 405024100 58,000 400 0.69 2,290 -2.01 0.0092
2017-05-12 2017-03-31 13F HAEMONETICS CORP MASS SC 405024100 57,600 0 0.00 2,337 0.91 0.0097
2017-02-07 2016-12-31 13F HAEMONETICS CORP MASS SC 405024100 57,600 2,900 5.30 2,316 16.91 0.0107
2016-11-10 2016-09-30 13F HAEMONETICS CORP MASS SC 405024100 54,700 54,700 0.00 1,981 0.0100
2016-08-11 2016-06-30 13F HAEMONETICS CORP MASS SC 405024100 0 -46 -100.00 0 -100.00
2016-05-11 2016-03-31 13F HAEMONETICS CORP MASS SC 405024100 46 46 0.00 2 0.0000
2014-11-13 2014-09-30 13F HAEMONETICS CORP MASS SC 405024100 0 -39 -100.00 0 -100.00
2014-08-13 2014-06-30 13F HAEMONETICS CORP MASS SC 405024100 39 -53 -57.61 1 -75.00 0.0000
2014-02-18 2013-12-31 13F HAEMONETICS CORP MASS SC 405024100 92 92 4 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.